NFA
RCKT icon

Nationwide Fund Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Nationwide Fund Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,747
Closed -$22K – 3246
2017
Q1 		$22K Hold
2,747
– – ﹤0.01% 3080
2016
Q4 		$67K Hold
2,747
– – ﹤0.01% 2957
2016
Q3 		$104K Hold
2,747
– – ﹤0.01% 2876
2016
Q2 		$82K Buy
+2,747
New +$96.6K ﹤0.01% 2984

Other funds holding RCKT

RCP
Rho Capital Partners New York $20.4M AUM
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Nationwide Fund Advisors's RCKT Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Rocket Pharmaceuticals (RCKT) in Q2 2017, closing a stake of 2,747 shares — an estimated $22K sold.

Nationwide Fund Advisors first reported a position in RCKT in Q2 2016 and held it in 4 quarters. The position peaked at $104K in Q3 2016. 51 funds tracked by Wall St. Rank hold RCKT as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining Rocket Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 2,747 Rocket Pharmaceuticals shares in Q2 2017, an estimated $22K.
  • Nationwide Fund Advisors first reported a position in Rocket Pharmaceuticals in Q2 2016 and held it in 4 quarters.
  • Nationwide Fund Advisors's Rocket Pharmaceuticals position peaked at $104K in Q3 2016.
  • 51 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.